Mergers News
Monday, August 22, 2016
REFILE-UPDATE 2-Pfizer boosts cancer drug pipeline with $14 bln Medivation deal
Aug 22 (Reuters) - Pfizer Inc said on Monday it
would buy U.S. cancer drug company Medivation Inc in a
deal valued at about $14 billion, adding blockbuster prostate
cancer drug Xtandi to its...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment